Protease-activated receptor 2 (PAR2) stimulation potentiates citric acid induced cough by sensitising the vanilloid receptor-1 (TRPV1)

M. Trevisani, A. Milan, S. Amadesi, S. Harrison, N. W. Bunnett, P. Geppetti (Ferrara, Florence, Italy; San Francisco, United States Of America)

Source: Annual Congress 2003 - Novel drugs under development for the treatment of respiratory diseases
Session: Novel drugs under development for the treatment of respiratory diseases
Session type: Oral Presentation
Number: 2554
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Trevisani, A. Milan, S. Amadesi, S. Harrison, N. W. Bunnett, P. Geppetti (Ferrara, Florence, Italy; San Francisco, United States Of America). Protease-activated receptor 2 (PAR2) stimulation potentiates citric acid induced cough by sensitising the vanilloid receptor-1 (TRPV1). Eur Respir J 2003; 22: Suppl. 45, 2554

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A new ultra-potent vanilloid receptor 1 (VR1) antagonist abates capsaicin and citric acid induced cough
Source: Eur Respir J 2002; 20: Suppl. 38, 190s
Year: 2002

The effect of leukotrienes and their receptor antagonists on calcium signalling in the cough receptors transient receptor potential ankyrin 1 (TRPA1) and vanilloid 1 (TRPV1)
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


Ethanol (EtOH) causes bronchoconstriction and plasma protein extravasation (PPE) in rodent airways via vanilloid receptor 1 (VR1) activation
Source: Eur Respir J 2002; 20: Suppl. 38, 485s
Year: 2002

Ethanol (EtOH) enhances the transient receptor potential vanilloid 1 (TRPV1) dependent cough in the guinea pig
Source: Eur Respir J 2004; 24: Suppl. 48, 94s
Year: 2004

Ethanol (EtOH) promotes Ca2+ mobilization and neuropeptide release from airway sensory nerves via vanilloid receptor 1 (VR1) activation
Source: Eur Respir J 2002; 20: Suppl. 38, 170s
Year: 2002

Different alcohols activate airway sensory nerves by a vanilloid receptor 1 (TRPV1) dependent mechanism
Source: Eur Respir J 2003; 22: Suppl. 45, 415s
Year: 2003

Hydrogen sulphide (H2S) modulates cough in the guinea pig activating/sensitising the transient receptor potential vanilloid 1 (TRPV1)
Source: Eur Respir J 2005; 26: Suppl. 49, 130s
Year: 2005

Nicotinic alpha-7 receptor stimulation (a7nAChR) inhibited NF-kB/STAT3/SOCS3 pathways in a murine model of asthma.
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017



Modulation of transient receptor potential vanilloid-1 (TRPV1) by inhaled prostaglandin-E2 (PGE2) and bradykinin (BK) is associated with increased cough sensitivity to capsaicin (CPS) and autonomic dysregulation of cardiac rhythm in healthy subjects
Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Year: 2020


Suppression of basophil activation via histamine receptor 2 (HR2)
Source: Eur Respir J 2005; 26: Suppl. 49, 585s
Year: 2005

Immunohistochemical localization of vanilloid receptor subtype 1 (TRPV1) in the guinea pig respiratory system
Source: Eur Respir J 2004; 24: Suppl. 48, 554s
Year: 2004

Nerve growth factor induces the expression of vanilloid receptor 1 in airway sensory neurons
Source: Eur Respir J 2002; 20: Suppl. 38, 385s
Year: 2002

Inhibition of cough reflex by D2 receptor agonism with Viozan™ (AR-C68397AA)
Source: Eur Respir J 2001; 18: Suppl. 33, 32s
Year: 2001

The endocannabinoids anandamide and 2-arachidonyl-glycerol (2-AG) induce pulmonary hypertension (PH) in a CB1 receptor independent manner - role of COX-2 and EP1 receptor activation
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005

Protease activated receptor-1 (PAR-1) stimulation leads to αvβ6 integrin mediated TGFβ activation via rho kinase
Source: Eur Respir J 2005; 26: Suppl. 49, 238s
Year: 2005

Cystenyl-leukotriene receptor antagonist (LRA) inhibits respiratory burst of human neutrophils
Source: Eur Respir J 2003; 22: Suppl. 45, 316s
Year: 2003

Effect of rifampin, a potent organic-anion-transporting polypeptide inhibitor (OATPi), on the PK of BMS-986278, a lysophosphatidic acid receptor (LPA1) antagonist
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020


Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
Source: ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020
Year: 2020



Enhanced platelet activating factor receptor (PAFR) expression in smoker airways
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011


Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020